- For advice on initiating warfarin in patients taking antiplatelet agents, see Warfarin anticoagulant advice.
- See guidance on use post-MI, post-TIA or ischaemic stroke and Acute cornonary syndrome.
- Antiplatelet drugs (aspirin and clopidogrel) are not recommended for primary prevention of cardiovascular disease.
Antiplatelet monotherapy (low dose aspirin or clopidogrel):
Antiplatelet dual therapy (low dose aspirin and clopidogrel/ticagrelor/prasugrel):
*Patients at high risk of infection with CDI are those with any of the following risk factors:
** Patients at high risk of GI adverse effects are those with any of the following risk factors: